Document is current
Any future updates will be listed below
-
Authors
Lee, Ming-Hsiang https://orcid.org/0000-0003-3174-8372
Liu, Christine S. https://orcid.org/0000-0002-1239-4612
Zhu, Yunjiao
Kaeser, Gwendolyn E.
Rivera, Richard
Romanow, William J.
Kihara, Yasuyuki https://orcid.org/0000-0001-7462-3006
Chun, Jerold https://orcid.org/0000-0003-3964-0921
- License Information
-
More Information
Article History
Received: 24 April 2020
Accepted: 18 May 2020
First Online: 19 August 2020
Competing interests
: Sanford Burnham Prebys Medical Discovery Institute has filed the following patent applications on the subject matter of this publication: (1) PCT application number PCT/US2018/030520 entitled, ‘Methods of diagnosing and treating Alzheimer’s disease’ filed 1 May 2018, which claims priority to US provisional application 62/500,270 filed 2 May 2017; and (2) US provisional application number 62/687,428 entitled, ‘Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer’s disease’ filed 20 June 2018. J.C. is a co-founder of Mosaic Pharmaceuticals.
